FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024 FDA EllieMD Dihexa March Roundup of FDA Approvals in Oncology: 4 Decisions to Know OncLive